A practical reference on fatty acid oxidation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-26 and is reviewed periodically as new material appears.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
| Property | Value | Notes |
|---|---|---|
| Chemical class | PPARδ agonist | Not an anabolic steroid. |
| Common synonyms | GW501516, GW-1516 | Cardarine is an informal name. |
| Appearance | White to off-white powder | Typical for research-grade solid. |
| Solubility class | Poorly soluble in water; soluble in some organic solvents | Such as DMSO or ethanol in laboratory settings. |
| Typical storage temperature | Cool, dry, protected from light | Specific conditions vary by supplier and form. |
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is explicitly prohibited by the World Anti-Doping Agency under the class of PPARδ agonists. Its presence in urine or blood samples can be detected using mass spectrometry-based methods, often liquid chromatography-tandem mass spectrometry. Athletes who test positive may face sanctions, including bans from competition. The compound is also regulated as a prescription-only or unapproved drug in many countries. Enforcement varies by jurisdiction, and some regions treat it as a controlled substance. Online sales may occur despite these restrictions, creating quality and legal risks.
Regulatory bodies treat GW501516 as a prohibited substance in competitive sport. The World Anti-Doping Agency added it to the prohibited list, and it falls under classes covering metabolic modulators and hormone-related agents. It is not approved by drug regulators for human use, and it is not a lawful dietary supplement. Products sold under the cardarine name may contain unlisted ingredients or different compounds. Because no approved product exists, quality and identity are not guaranteed by pharmaceutical manufacturing standards.
Cardarine is a common name for the investigational chemical GW501516, also written GW-1516. It was developed as a peroxisome proliferator-activated receptor delta agonist for metabolic conditions such as dyslipidemia. Early research focused on lipid handling and energy use in skeletal muscle and other tissues. The compound was never approved as a medicine. In public discussion, it is often grouped with performance-enhancing substances, although its receptor target differs from that of anabolic steroids or selective androgen receptor modulators. Regulatory and health authorities have issued warnings about its use.
GW501516 acts on PPARδ, a nuclear receptor that helps regulate fatty acid oxidation and energy homeostasis. In animal studies, activation of this receptor was associated with increased endurance and changes in lipid metabolism. Human trials examined effects on blood lipids and other metabolic markers, but the compound did not advance to approval. Rodent studies later reported tumors in multiple tissues at doses used in those experiments. Whether those findings translate to human risk remains uncertain, and the clinical relevance of the animal data is still debated.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.
Absinthe's popularity grew steadily through the 1840s, when it was given to French troops in Algeria as a malaria preventive, and the troops brought home their taste for it. Absinthe became so popular in bars, bistros, cafés, and cabarets by the 1860s that the hour of 5 pm was called l'heure verte 'the green hour'. It was favoured by all social classes, from the wealthy bourgeoisie to poor artists and ordinary working-class people. By the 1880s, mass production had caused the price to drop sharply, and the French were drinking 36 million litres (9,500,000 US gal) per year by 1910. Absinthe was exported widely from France and Switzerland and attained some degree of popularity in other countries, including Spain, the United Kingdom, the United States, and the Czech Republic. It was never banned in Spain or Portugal, and its production and consumption have never ceased. It gained a temporary popularity spike during the early 20th century, corresponding with the Art Nouveau and Modernism aesthetic movements. New Orleans has a cultural association with absinthe and is credited as the birthplace of the Sazerac, perhaps the earliest absinthe cocktail. The Old Absinthe House bar on Bourbon Street began selling absinthe in the first half of the 19th century. Its Catalan lease-holder, Cayetano Ferrer, named it the Absinthe Room in 1874 due to the drink's popularity, which was served in the Parisian style. It was frequented by Mark Twain, Oscar Wilde, Franklin Delano Roosevelt, Aleister Crowley, and Frank Sinatra.
== Structure == The activin and inhibin protein complexes are both dimeric in structure, and, in each complex, the two monomers are linked to one another by a single disulfide bond. In addition, both complexes are derived from the same family of related genes and proteins but differ in their subunit composition. Below is a list of the most common inhibin and activin complexes and their subunit composition:
=== Systemic antifungal === Ketoconazole has activity against many kinds of fungi that may cause human disease, such as Candida, Histoplasma, Coccidioides, and Blastomyces (although it is not active against Aspergillus), chromomycosis and paracoccidioidomycosis. First made in 1977, ketoconazole was the first orally-active azole antifungal medication. However, ketoconazole has largely been replaced as a first-line systemic antifungal medication by other azole antifungal agents, such as fluconazole and/or itraconazole, because of ketoconazole's greater toxicity, poorer absorption, and more limited spectrum of activity. Ketoconazole is used orally in dosages of 200 to 400 mg per day in the treatment of superficial and deep fungal infections.
== Operations == Most cafés are company-owned and located in urban centres, shopping malls, business districts, and transport hubs, with some sites franchised. The chain serves espresso-based drinks, filter coffee, cold brew, tea, hot chocolate and seasonal beverages, alongside pastries and light food. Packaged coffee beans, including organic blends, are sold in cafés and online. A loyalty app provides discounts and pre-ordering options. Caffeine is noted in local media for helping spread takeaway coffee and laptop-friendly café culture in cities such as Vilnius, Kaunas and Klaipėda. The company promotes sustainability through its organic-coffee policy, reusable-cup incentives and co-location of some sites with electric-vehicle charging hubs operated by Eldrive Lithuania.
Sources: en.wikipedia.org
== Ester terminology == IUPAC states normatively that carbamate "esters are often called urethanes or urethans, a usage that is strictly correct only for the ethyl esters." However, as a descriptive matter, the IUPAC recognizes that "An alternative term for the compounds R2NC(=O)OR' (R' not = H), esters of carbamic acids, R2NC(=O)OH, in strict use limited to the ethyl esters, but widely used in the general sense".
=== Bridging projects === The enolase superfamily contains evolutionarily related enzymes with a (β/α)7β‑barrel (TIM‑barrel) fold which primarily catalyze metal-assisted epimerization/racemization or β-elimination of carboxylate substrates. The Haloacid dehydrogenase superfamily contains evolutionarily related enzymes with a Rossmanoid α/β fold with an inserted "cap" region which primarily catalyze metal-assisted nucleophilic catalysis, most frequently resulting in phosphoryl group transfer. The isoprenoid synthase (I) superfamily contains evolutionarily related enzymes with a mostly all α-helical fold and primarily catalyze trans-prenyl transfer reactions to form elongated or cyclized isoprene products. The Anaerobic Enzymology bridging project will explore radical-dependent enzymology, which allows the execution of unusual chemical transformations via an iron-sulfur cluster cleaving S-Adenosyl methionine (SAM) and producing a radical intermediate, or alternatively, abstraction of a hydrogen from glycine producing a glycyl radical. The superfamilies containing these enzymes are largely unexplored and thus, ripe with the potential for functional discoveries. The acquisition of an anaerobic protein production pipeline coupled with the installation of a Biosafety Level 2 anaerobic chamber for culturing human gut microbes has readied the EFI to pursue anaerobic enzymology.
Dinosterol has been used as an indicator for dinoflagellate production in the Cariaco Basin. In such studies, it has been revealed that the accumulation of dinosterol peaks at a rate of almost 900 mg compound/cm2/yr during the Younger Dryas. Hydrogen isotope ratios in dinosterols can serve to reconstruct salinity semi-quantitatively. Some studies have revealed that certain dinoflagellates produce sterols that have the potential to serve as genera-specific biomarkers. Recent work showed that dinoflagellate genera, which formed discrete clusters in the 18S rDNA-based phylogeny, shared similar sterol compositions. This suggested that the sterol compositions of dinoflagellates are explained by the evolutionary history of this lineage.
==== Member of the Order of the British Empire (MBE) ==== Military Commander Steven Andrews, Royal Navy, D257452S. Lieutenant Commander Ross Donald Balfour, Royal Navy, C040712E. Warrant Officer 1 James Adrian Cuthbert, Royal Marines, P047210N. Warrant Officer 1 Engineering Technician (Communication and Information Systems) Steven Gilbertson, Royal Navy, D242982T. Commander Martin John Howard, Royal Navy, C041681L. Lieutenant Commander Alexander Rowan Marsh, Royal Navy, 30033538. Commander Paul O'Dooley, Royal Naval Reserve, C900344D. Chief Petty Officer Engineering Technician (Marine Engineering) Michael John Stephens, Royal Navy, D258366B. Leading Seaman (Diver) Rory Edward Cartwright-Taylor, Royal Navy, 30050838. Lieutenant Sam David Thompson, Royal Navy, 30023663. Commander Roger Simon Wyness, Royal Navy, C037182G. Major John Edward BAILEFF, Royal Regiment of Artillery, 30121479. Major Allan Paul Beard, Intelligence Corps, 25132230. Sergeant Daniel Adam Powderham-Bissell, Intelligence Corps, 25179642. Lieutenant Colonel John George Bradbury, Corps of Royal Electrical and Mechanical Engineers, Army Reserve, 552247. Major (now Acting Lieutenant Colonel) Keith Michael Timothy Brooks, , Royal Regiment of Artillery, Army Reserve, 511819. Captain Barry Lee Byron, , General Service Corps, Army Reserve, 24751476. Captain Giles Alexander Leighton Clarke, The Royal Logistic Corps, 30082571. Major Lisa Jane Clarke, Adjutant General's Corps (Staff and Personnel Support Branch), W0815832. Major James Philip Dott, The Parachute Regiment, 30011021.
MassMatrix is a mass spectrometry data analysis software that uses a statistical model to achieve increased mass accuracy over other database search algorithms. This search engine is set apart from others dues to its ability to provide extremely efficient judgement between true and false positives for high mass accuracy data that has been obtained from present day mass spectrometer instruments. It is useful for identifying disulphide bonds in tandem mass spectrometry data. This search engine is set apart from others due to its ability to provide extremely efficient judgement between true and false positives for high mass accuracy data that has been obtained from present day mass spectrometer instruments.
Sources: en.wikipedia.org
=== Variable contact rates === It is well known that the probability of getting a disease is not constant in time. As a pandemic progresses, reactions to the pandemic may change the contact rates which are assumed constant in the simpler models. Counter-measures such as masks, social distancing, and lockdown will alter the contact rate in a way to reduce the speed of the pandemic. In addition, Some diseases are seasonal, such as the common cold viruses, which are more prevalent during winter. With childhood diseases, such as measles, mumps, and rubella, there is a strong correlation with the school calendar, so that during the school holidays the probability of getting such a disease dramatically decreases. As a consequence, for many classes of diseases, one should consider a force of infection with periodically ('seasonal') varying contact rate
The Alexander von Humboldt Fellowship to Germany (2003–2005) Visiting Scientist to the University of Pittsburgh, (2007–2008) The ANDI Bright Contest Award for the Best African Innovative Researcher, South Africa (2009) Young Scientist (representing Nigeria) at the "Summer Davos" Annual Meeting of New Champions, Tianjin, China (2010) CV Raman Senior Fellowship, India (2013) Fellow of the Nigerian Academy of Science (2017) Pioneer national president of the Nanomedicine Society of Nigeria Recipient of various national and international grants and a reviewer to several national and international journals.
== Laboratory methods == Hemoglobin A2 has a crucial role in screening and diagnosis of the beta-thalassemia trait. Various laboratory methods exist, each providing different outcomes of accuracy. The different quantification methods of HbA2 relies on how effective it can be separated from other hemoglobin variants. Various laboratory methods are employed, such as cation exchange high-performance liquid chromatography (HPLC), microcolumn chromatography, and cellulose acetate electrophoresis with elution. At first, cellulose acetate electrophoresis was utilized to measure HbA2, but this process proved to be too time-consuming and labor-intensive, making it impractical for large examinations or samples. Similar efficiency issues were encountered with other methods like IEF and scanning densitometry. These two methods separate proteins based on their isoelectric point. Chromatography, another commonly used method, demonstrated reliability in diagnosing individuals with the beta carrier gene. However, this method was also time-consuming and inefficient when dealing with large sample numbers. Out of the various methods, the one that accurately measures HbA2 is HPLC. It is a reliable technique because it's able to accurately determine HbA2, HbF, and Hb variants. The various different Hb variants include: HbS, HbE, Hb Lepore, HbC, HbD and HbO-Arab. There are several different factors that can contribute to the quantification of HbA2 to be inaccurately measured.
It is advised to check the references for photos of reaction results. Reagent testers might show the colour of the desired substance while not showing a different colour for a more dangerous additive. For this reason it is essential to use multiple different tests to show all adulterants.
=== World War I === In 1916, BASF started operations at a new site in Leuna, where explosives were produced during the First World War. On 21 September 1921, an explosion occurred in Oppau, killing 565 people. The Oppau explosion was the biggest industrial accident in German history.
Sources: en.wikipedia.org
Cardarine is commonly known as GW501516 or GW-1516. These names refer to the same synthetic compound. It is not a brand-name approved medicine.
No, cardarine is not a steroid. It is classified as a PPARδ agonist. Its structure and receptor target differ from anabolic steroids.
No regulatory agency has approved cardarine as a medicine. It was investigated in early research but development was discontinued. It is not available as a prescription drug.
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.